제도 환경 변화와 조직 변화: 경제성 평가의 도입과 다국적 제약기업의 조직 적응에 대한 다중사례연구 = Institutional Change and Organizational Change: A Multicase Study on the Organizational Adaptation to the Introduction of Pharmacoeconomics

다국어 초록 (Multilingual Abstract)

Background: Organizations in the pharmaceutical industry are highly dependent on the institutional environment. The introduction of pharmacoeconomics to the decision-making on the price and reimbursement decisions became strong constraints to pharmaceutical companies in Korea. As little is known about the issue on organization-environment interaction in the healthcare field, this study aimed to figure out how pharmaceutical companies adapted to the environmental changes.
Methods: A multicase study method was used, selecting eight cases among multi-national pharmaceutical companies in South Korea. In-depth interviews were conducted with the managers of these organizations, and secondary data were reviewed to complement the interviews.
Results: Pharmaceutical companies viewed the new policies as a big threat and sought for actions against them. One of the most distinguishing organizational changes was to construct a Market Access department. Other strategies managing the environment such as co-optation, forecasting, and bargaining were also implemented. These changes were consistent with the predictions of Resource Dependency Theory and Institutional Theory.
Conclusions: The interactions between pharmaceutical companies and institutional environments in healthcare were first explored. This study presents a new perspective on how organizations change and the motives for the changes. The findings of this case study will form the basis of further empirical studies.

참고문헌 (Reference)

1 유홍준, "한국 제약산업의 시장구조에 대한 신경제사회학적 분석" 29 : 291-319, 1995

2 Creswell JW, "질적 연구방법론 : 다섯 가지 접근" 학지사 2010

3 김정선, "종합병원의 경영전략 변화에 따른 조직구성원의 적응에 관한 사례연구" 4 : 31-54, 1998

4 박현우, "제약분야 기술거래의 로열티 결정구조와 요인" 한국기술혁신학회 10 (10): 406-430, 2007

5 나영, "전략적 의사결정지원을 위한 병원 원가관리시스템으로서의 ABC구축 사례연구"

6 배은영, "의약분업이 제약산업에 미친 영향" 31-39, 2002

7 유명순, "우리나라 보건의료 조직 연구의 현황과 과제" 한국보건행정학회 20 (20): 155-182, 2010

8 이선희, "양방과 한방 의료 이용자의 - D병원의 사례를 중심으로 서비스 선택요인 비교분석" 한국보건행정학회 12 (12): 18-33, 2002

9 김영숙, "약제비 증가요인 분석 및 관리방안" 국민건강보험공단 건강보험정책연구원 2009

10 이의경, "신의료기술 등의 경제성 평가 및활용을 위한 정책 방안: 의약품을 중심으로. 기본연구과제 2005-02"

11 이영철, "사회과학에서 사례연구의 이론적 지위: 비판적 실재론을 바탕으로" 한국행정학회 40 (40): 71-90, 2006

12 Yin RK, "사례연구방법" 한경사 2005

13 김성옥, "보험약가 결정방식 개선방안: 위험분담방식 적용을 중심으로 한 약가협상력 제고 방안" 국민건강보험공단 건강보험정책연구원 2009

14 이희영, "건강보험 진료비 증가요인 분석" 국민건강보험공단 건강보험정책연구원 2010

15 "건강보험 약제비 적정화 방안. 보도자료"

16 윤희숙, "건강보험 약가제도의 문제점과 개선방향 in 정책연구시리즈 2008-01" 한국개발연구원 2008

17 신현웅, "건강보험 내실화를 위한 재정효율화 방안: 본인부담 구조조정 방안 중심으로" 한국보건사회연구원 2009

18 최삼철, "[사례연구]사립학교법인의 설립병원에 대한 지방세부과처분취소에 관한 실태연구"

19 Caronna CA, "Turning Identity into Form: The Cause and Consequence for KaiserPermanente of becoming an HMO" 25 : 309-336, 2007

20 Baum JAC, "Toward an Institutional Ecology of Organizational Founding" 39 (39): 1378-1427, 1996

21 Katz D, "The social psychology of organizations" Wiley 1966

22 DiMaggio PJ, "The Iron Cage Revisited: Institutional Isomorphism andCollective Rationality in Organizational Fields" 48 (48): 147-160, 1983

23 Pfeffer J, "The External control of organizations : a resourcedependence perspective" Harper 1978

24 Selznick P, "TVA and the grass roots : a study in the sociology of formalorganization" Univ. of California Press 1953

25 Emerson RM, "Power-Dependence Relations" 27 (27): 31-41, 1962

26 Ulrich D, "Perspectives in Organizations: Resource Dependence,Efficiency, and Population" 9 (9): 471-481, 1984

27 Thompson JD, "Organizations in action : social science bases of administrative theory" McGraw-Hill 1967

28 Scott WR, "Organizations : rational, natural, and open systems 5th ed" Prentice Hall; 2003

29 Lawrence PR, "Organization and environment : managing differentiationand integration" Division of Research, Graduate School of BusinessAdministration, Harvard University 1967

30 정영호, "OECD 국가의 의약품산업 무역구조 분석" 47-57, 2001

31 Williamson OE, "Markets and hierarchies, analysis and antitrust implications :astudy in the economics of internal organization" Free Press 1975

32 Meyer JW, "Institutionalized organizations: Formal structure as mythand ceremony" 83 : 340-363, 1977

33 Kennedy MT, "Institutionalization, Framing, and Diffusion: The Logic of TQM Adoption and Implementation Decisions Among U.S. Hospitals" 52 (52): 897-918, 2009

34 Scott WR, "Institutional change and healthcareorganizations : from professional dominance to managed care" University of Chicago Press 2000

35 Sherer PD, "Institutional Change in Large Law Firms: A ResourceDependency and Institutional Perspective" 45 (45): 102-119, 2002

36 Lee J, "Innovation and Strategic Divergence: An Empirical Study of the U. S.Pharmaceutical Industry from 1920 to 1960" 49 (49): 143-159, 2003

37 Kim CY, "Health technology assessment in South Korea" 25 : 219-223, 2009

38 Health at a Glance, "Health at a Glance 2009" OECD 2009

39 Kitchener M, "From the doctor's workshop to the ironcage? Evolving modes of physician control in US health systems" 60 (60): 1311-1322, 2005

40 Dill WR, "Environment as an Influence on Managerial Autonomy" 2 (2): 409-443, 1958

41 Walston Sl Fau, "Doesreengineering really work? An examination of the context and outcomes ofhospital reengineering initiatives" 34 (34): 2000

42 Carroll GR, "Density Dependence in the Evolution of Populations ofNewspaper Organizations" 54 (54): 524-41, 1989

43 윤재희, "ABC를 이용한 병원의 원가관리" 4 (4): 295-327, 2003

44 Perrow C, "A Framework for the Comparative Analysis of Organizations" 32 (32): 194-208, 1967

45 정우진, "21세기에 대비한 제약산업의 발전방향" 14-25, 1997

46 이근찬, "2009년 의약품 산업 분석 보고서" 보건산업진흥원 15-17, 2009